Announcements Trials
Browse Landscape

Status

Recruiting 5Completed 3No longer available 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Thyroid cancer, medullary 1Pheochromocytoma 1Paraganglioma 1Neuroblastoma 1Insulinoma 1Carcinoid Tumor 1

Interventions

Ga(III)-DOTATOC 23-Iodobenzylguanidine 2surufatinib 1pegfilgrastim 1gallium Ga 68 dotatate 1fluorodopa F 18 1Vorinostat 1Potassium Iodide 1Granulocyte Colony-Stimulating Factor 1Gallium-68 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × fluorodopa F 18 × Endocrine × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡